PKU2- IMPROVEMENTS IN CLINICAL OUTCOMES, HEALTH-RELATED QUALITY OF LIFE (HRQoL) AND SYMPTOM BOTHER FOR OVERACTIVE BLADDER PATIENTS TREATED WITH A NEW ONCE-DAILY FORMULATION OF OXYBUTYNIN
Abstract
Authors
D Lubeck L Prebil L Potter P Peeples